Delivery Order SPE2DB25D3020-SPE2DB25FWKKA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Orgovyx 120 mg tablets (quantity: 30 units) under a firm fixed price contract. The award, valued at $16,626.24, has an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This competitively awarded, non-set-aside delivery order represents a single procurement action against AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52 and a firm fixed price structure. This delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), is scheduled for completion by September 12, 2025. The award was made through open competition with...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 28, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a specialized pharmaceutical used in the treatment of prostate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,385.52, with an ultimate completion date of September 23, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The contract ceiling value is $1,385.52, with an ultimate completion date of September 10, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This $2,771.04 firm fixed-price delivery order will be fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 22, 2025. The contract carries no set-aside designation and was competitively awarded through open procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a purchase of pharmaceutical products to support federal medical procurement needs, with performance to occur at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $2,771.04 and an ultimate completion date of August 11, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,385.52, is scheduled for completion by August 14, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The contract was competitively awarded without set-aside provisions, reflecting AmerisourceBergen's capability to meet federal...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKKADelivery Order
The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation, indicating the award was made through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor under this comprehensive global contract vehicle, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The IDC enables the company to fulfill critical medical needs across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard, with this specific order for Orgovyx—a prostate cancer treatment—representing a typical component of the company's extensive federal medical supply portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/3/25 |